Walder Wyss advised Versant Ventures on the deal. VISCHER advised Cimeo Therapeutics.Versant Ventures announced the debut of Cimeio Therapeutics, a biotechnology company developing a novel approach…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
